FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,543,342 | 3.52% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,664,303 | 2.68% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4,058,553 | 1.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,354,258 | $3,521,071 | 0.64% |
| Avidity Partners Management LP | 5,781,850 | $15,032,810 | 0.60% |
| Eagle Health Investments LP | 579,769 | $1,507,399 | 0.33% |
| Perceptive Advisors | 2,751,395 | $7,153,627 | 0.24% |
| Ghost Tree Capital, LLC | 243,287 | $632,546 | 0.21% |
| Sio Capital Management, LLC | 246,036 | $639,694 | 0.20% |
| Artal Group S.A. | 1,725,000 | $4,485 | 0.19% |
| Orbimed Advisors | 3,122,770 | $8,119,202 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,823,000 | $7,339,800 | 0.16% |
| TPG GP A, LLC | 2,551,794 | $6,634,664 | 0.11% |
| FEDERATED HERMES, INC. | 10,683,789 | $27,777,851 | 0.07% |
| Forefront Analytics, LLC | 33,685 | $87,581 | 0.05% |
| SECTORAL ASSET MANAGEMENT INC | 57,297 | $148,972 | 0.03% |
| Sofinnova Investments, Inc. | 117,099 | $304,457 | 0.02% |
| UBS OCONNOR LLC | 274,568 | $713,877 | 0.02% |
| CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 | $8,104,112 | 0.01% |
| NEOS Investment Management LLC | 17,493 | $45,482 | 0.01% |
External links
This page lists FUSION PHARMACEUTICALS INC's shareholders in Q3 2023. To view FUSION PHARMACEUTICALS INC's shareholder history, click here.